Dexa/Juicebox

Published Dec 13, 2022

#808 Teplizumab Trial Participant

Adele shares her profound journey through her son's type 1 diabetes diagnosis and her family's involvement in the Teplizumab trial, revealing insights into the importance of intuition, community support, and the transformative potential of medical advancements in managing chronic illness with resilience and hope.

Episode Highlights

Topics covered

Questions from this episode

- What are the benefits of AG1?
  Asked by 240 people
- What is AG1 (Athletic Greens)?
  Asked by 52 people
- What's in Athletic Greens?
  Asked by 33 people
- What are the key benefits of AG1?
  Asked by 32 people
- What do world-leading experts generally say about the benefits of AG1?
  Asked by 22 people
- Which supplement brand is better for intense motivation, J's Health Vitamins or Athletic Greens (AG1)?
  Asked by 18 people
- What are the specific benefits of AG1?
  Asked by 14 people
- What are the main ingredients in AG1 (Athletic Greens)?
  Asked by 10 people
- What ingredients are included in AG One?
  Asked by 9 people
- According to expert analysis and great research, list every single possible proven significant benefit of AG1, from mood and motivation all the way to eye health
  Asked by 4 people
- Is AG1 beneficial and in what way?
  Asked by 4 people
- Is AG1 Green worth it?
  Asked by 1 person

Episode Highlights

Related Episodes

#452 Learning about Teplizumab
Answers 383 questions
#848 TZIELD Trial Participant
Answers 383 questions
#724 Downton Podcast
Answers 383 questions
#692 Afrezza Trial
Answers 383 questions
#928 Juicebox Assistance
Answers 383 questions
#533 Not That Type
Answers 383 questions
#962 Baby Catcher
Answers 383 questions
#783 Survey Says
Answers 383 questions
#1109 Type 3c Diabetes
Answers 383 questions
#836 Best of Juicebox: Explaining Type 1
Answers 383 questions
#721 Cutting It Up
Answers 383 questions
#950 Life Story
Answers 383 questions
#207 A Cool Bond
Answers 383 questions
#903 Season of the Witch
Answers 383 questions
#633 ViaCyte Trial Participant
Answers 383 questions